Diseases and Drugs That Increase Risk of Acute Large Bowel Ischemia

Clinical Gastroenterology and Hepatology

Volumn 8, Issue 1, 2010, Pages 49-54

  Longstreth, George F ^a   Yao, Janis F ^b  

^a Kaiser Permanente Medical Care Plan ^*  (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; CLOPIDOGREL; DIGOXIN; DIPHENOXYLATE; DIPYRIDAMOLE; ERGOTAMINE DERIVATIVE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOMODULATING AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PHENTERMINE; PSEUDOEPHEDRINE; SEROTONIN AGONIST; SEX HORMONE; TAXANE DERIVATIVE; TEGASEROD; TICLOPIDINE; VINCA ALKALOID;

ADULT; AGED; ANTICHOLINERGIC EFFECT; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONSTIPATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIALYSIS; DIARRHEA; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INTESTINE ISCHEMIA; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTESTINE, LARGE; ISCHEMIA; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; RISK FACTORS;

EID: 72049097118     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.09.006     Document Type: Article

References (33)

1. Brandt L.J., Boley S.J., and American Gastroenterological Association Clinical Practice and Practice Economics Committee. AGA technical review on intestinal ischemia. Gastroenterology 118 (2000) 954-968
2. Cappell M.S. Intestinal (mesenteric) vasculopathy II. Gastroenterol Clin North Am 27 (1998) 827-860
3. Gandhi S.K., Hanson M.M., Vernava A.M., et al. Ischemic colitis. Dis Colon Rectum 39 (1996) 88-100
4. Longstreth G.F., and Yao J.F. Acute large bowel ischemia: a retrospective study of epidemiology, clinical features, high-risk factors, and outcome. Clin Gastroenterol Hepatol 7 (2009) 1075-1080
5. Hass D.J., Kozuch P., and Brandt L.J. Pharmacologically mediated colon ischemia. Am J Gastroenterol 102 (2007) 1765-1780
6. Park C.J., Jang M.K., Shin W.G., et al. Can we predict the development of ischemic colitis among patients with lower abdominal pain?. Dis Colon Rectum 50 (2006) 232-238
7. Guttormson N.L., and Bubrick M.P. Mortality from ischemic colitis. Dis Colon Rectum 32 (1989) 469-472
8. Longo W.E., Ballantyne G.H., and Gusberg R.J. Ischemic colitis: patterns and prognosis. Dis Colon Rectum 35 (1992) 726-730
9. Habu Y., Tahashi Y., Kiyota K., et al. Reevaluation of clinical features of ischemic colitis. Scand J Gastroenterol 31 (1996) 881-886
10. Flobert C., Cellier C., Berger A., et al. Right colonic involvement is associated with severe forms of ischemic colitis and occurs frequently in patients with chronic renal failure requiring hemodialysis. Am J Gastroenterol 95 (2000) 195-198
11. Scharff J.R., Longo W.E., Vartanian S.M., et al. Ischemic colitis: spectrum of disease and outcome. Surgery 134 (2003) 624-630
12. Medina C., Vilaseca J., Videla S., et al. Outcome of patients with ischemic colitis: review of fifty-three cases. Dis Colon Rectum 47 (2004) 180-184
13. Huguier M., Barrier A., Boelle P.Y., et al. Ischemic colitis. Am J Surg 192 (2006) 679-684
14. Sotiriadis J., Brandt L.J., Behin D.S., et al. Ischemic colitis has a worse prognosis when isolated to the right side of the colon. Am J Gastroenterol 102 (2007) 2247-2252
15. Menegaux F., Trésallet C., Kieffer E., et al. Aggressive management of nonocclusive ischemic colitis following aortic reconstruction. Arch Surg 141 (2006) 678-682
16. Walker A.M., Bohn R.L., Cali C., et al. Risk factors for colon ischemia. Am J Gastroenterol 99 (2004) 1333-1337
17. Chang L., Kahler K.H., Sarawate C., et al. Assessment of potential risk factors associated with ischemic colitis. Neurogastroenterol Motil 20 (2008) 36-42
18. Cole J.A., Cook S.F., Sands B.E., et al. Occurrence of colon ischemia in relation to irritable bowel syndrome. Am J Gastroenterol 99 (2004) 486-491
19. Suh D.-C., Kahler K.H., Choi I.-S., et al. Patients with irritable bowel syndrome or constipation have an increased risk for ischemic colitis. Aliment Pharmacol Ther 25 (2007) 681-692
20. Longstreth G.F., Thompson W.G., Chey W.D., et al. Functional bowel disorders. In: Drossman D.A. (Ed). The functional gastrointestinal disorders. 3rd ed. (2006), Degnon, McLean, VA
21. Drazner M.H., Rame J.E., Marino E.K., et al. Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study. J Am Coll Cardiol 43 (2004) 2207-2215
22. Viswanathan K., Daniak S.M., Salomone K., et al. Effect of cardioversion of atrial fibrillation on improvement in left ventricular performance. Am J Cardiol 88 (2001) 439-441
23. Hourmand-Ollivier I., Bouin M., Saloux E., et al. Cardiac sources of embolism should be routinely screened in ischemic colitis. Am J Gastroenterol 98 (2003) 1573-1577
24. Cook S.F., Lanza L., Zhou X., et al. Gastrointestinal side effects in chronic opioid users: results from a population-based survey. Aliment Pharmacol Ther 27 (2008) 1224-1232
25. Kamm M.A., Jordan C.C., Leaker B.R., et al. Pharmacological modulation of gut mucosal and large vessel blood flow. Aliment Pharmacol Ther 25 (2007) 693-702
26. Drossman D.A., Li Z., Andruzzi E., et al. U.S. householder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact. Dig Dis Sci 38 (1993) 1569-1580
27. O'Donnell L.J.D., Virjee J., and Heaton K.W. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit time. Br Med J 300 (1990) 439-440
28. Nadar S., Blann A.D., and Lip G.Y. Endothelial dysfunction: methods of assessment and application to hypertension. Curr Pharm Des 10 (2004) 3591-3605
29. Su Y., Liu X.M., Sun Y.M., et al. Endothelial dysfunction in impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes mellitus. Am J Cardiol 102 (2008) 497-498
30. Gonzales-Gay M.A., Gonzales-Juanatey C., Vazquez-Rodriguez T.R., et al. Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum 38 (2008) 67-70
31. Manabe N., Tanaka T., Hata J., et al. Pathophysiology underlying irritable bowel syndrome-from the viewpoint of dysfunction of autonomic nervous system activity. J Smooth Muscle Res 45 (2009) 15-23
32. Rosenblum J.D., Boyle C.M., and Schwartz L.B. The mesenteric circulation. Anatomy and physiology. Surg Clin North Am 77 (1997) 289-306
33. Peduzzi P., Concato J., Kemper E., et al. A stimulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49 (1996) 1373-1379